Re-DiffiNet: Modeling discrepancies loss in tumor segmentation using diffusion models

Identification of tumor margins is essential for surgical decision-making for glioblastoma patients and provides reliable assistance for neurosurgeons. Despite improvements in deep learning architectures for tumor segmentation over the years, creating a fully autonomous system suitable for clinical floors remains a formidable challenge because the model predictions have not yet reached the desired level of accuracy and generalizability for clinical applications. Generative modeling techniques have seen significant improvements in recent times. Specifically, Generative Adversarial Networks (GANs) and Denoising-diffusion-based models (DDPMs) have been used to generate higher-quality images with fewer artifacts and finer attributes. In this work, we introduce a framework called Re-Diffinet for modeling the discrepancy between the outputs of a segmentation model like U-Net and the ground truth, using DDPMs. By explicitly modeling the discrepancy, the results show an average improvement of 0.55\% in the Dice score and 16.28\% in HD95 from cross-validation over 5-folds, compared to the state-of-the-art U-Net segmentation model.

An Optimization Framework for Processing and Transfer Learning for the Brain Tumor Segmentation

Tumor segmentation from multi-modal brain MRI images is a challenging task due to the limited samples, high variance in shapes and uneven distribution of tumor morphology. The performance of automated medical image segmentation has been significant improvement by the recent advances in deep learning. However, the model predictions have not yet reached the desired level for clinical use in terms of accuracy and generalizability. In order to address the distinct problems presented in Challenges 1, 2, and 3 of BraTS 2023, we have constructed an optimization framework based on a 3D U-Net model for brain tumor segmentation. This framework incorporates a range of techniques, including various pre-processing and post-processing techniques, and transfer learning. On the validation datasets, this multi-modality brain tumor segmentation framework achieves an average lesion-wise Dice score of 0.79, 0.72, 0.74 on Challenges 1, 2, 3 respectively.

3D Inception-Based TransMorph: Pre- and Post-operative Multi-contrast MRI Registration in Brain Tumors

Deformable image registration is a key task in medical image analysis. The Brain Tumor Sequence Registration challenge (BraTS-Reg) aims at establishing correspondences between pre-operative and follow-up scans of the same patient diagnosed with an adult brain diffuse high-grade glioma and intends to address the challenging task of registering longitudinal data with major tissue appearance changes. In this work, we proposed a two-stage cascaded network based on the Inception and TransMorph models. The dataset for each patient was comprised of a native pre-contrast (T1), a contrast-enhanced T1-weighted (T1-CE), a T2-weighted (T2), and a Fluid Attenuated Inversion Recovery (FLAIR). The Inception model was used to fuse the 4 image modalities together and extract the most relevant information. Then, a variant of the TransMorph architecture was adapted to generate the displacement fields. The Loss function was composed of a standard image similarity measure, a diffusion regularizer, and an edge-map similarity measure added to overcome intensity dependence and reinforce correct boundary deformation. We observed that the addition of the Inception module substantially increased the performance of the network. Additionally, performing an initial affine registration before training the model showed improved accuracy in the landmark error measurements between pre and post-operative MRIs. We observed that our best model composed of the Inception and TransMorph architectures while using an initially affine registered dataset had the best performance with a median absolute error of 2.91 (initial error = 7.8). We achieved 6th place at the time of model submission in the final testing phase of the BraTS-Reg challenge.